IDH1 and central nervous system cancer: A recent study used an MRI-based deep-learning method to classify glioma IDH mutation status using preoperative T2-weighted images and obtained a best mean cross-validation accuracy of 97.14% ± 0.04 in predicting IDH mutation (Bangalore Yogananda et al. 2020).